Biblio Discovery — Demo Discovery Service

3 hasil untuk "Mu-Peng Li"

Menampilkan 1–3 · 0,28 detik · RSS

  1. Artikel Jurnal

    High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia

    Gang-Zhi Zhu; Yong-Long Yang; Yan-Jiao Zhang dkk.

    Cellular Physiology and Biochemistry, Vol. 42 No. 5 · 2017 · Inggris · DOAJ Scopus

    Background/Aims: Acute myeloid leukemia (AML) is a heterogeneous clonal disease and patients with AML who harbor an FMS-like tyrosine kinase 3 (FLT3) mutation present several dilemmas for the clinician. This study aims to identify novel targets for explaining the dilemmas. Methods: We analyzed four…

  2. Artikel Jurnal

    Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease

    He Li; Yan-Jiao Zhang; Mu-Peng Li dkk.

    Frontiers in Pharmacology, Vol. 9 · 2018 · Inggris · DOAJ Scopus

    Dual antiplatelet treatment with aspirin and clopidogrel is the standard therapy for patients undergoing percutaneous coronary intervention (PCI). However, a portion of patients suffer from clopidogrel resistance (CR) and consequently with recurrence of cardiovascular events. Genetic factors such…

  3. Artikel Jurnal

    Influence of GAS5/MicroRNA‐223‐3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease

    Yan‐Ling Liu; Xiao‐Lei Hu; Pei‐Yuan Song dkk.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 10 No. 21 · 2021 · Inggris · DOAJ Scopus

    Background Dual antiplatelet therapy based on aspirin and P2Y12 receptor antagonists such as clopidogrel is currently the primary treatment for coronary artery disease (CAD). However, a percentage of patients exhibit clopidogrel resistance, in which genetic factors play vital roles. This study…